{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["41(1)"],"submitter":["Barbieri F"],"pubmed_abstract":["<h4>Background</h4>Chloride intracellular channel-1 (CLIC1) activity controls glioblastoma proliferation. Metformin exerts antitumor effects in glioblastoma stem cells (GSCs) inhibiting CLIC1 activity, but its low potency hampers its translation in clinical settings.<h4>Methods</h4>We synthesized a small library of novel biguanide-based compounds that were tested as antiproliferative agents for GSCs derived from human glioblastomas, in vitro using 2D and 3D cultures and in vivo in the zebrafish model. Compounds were compared to metformin for both potency and efficacy in the inhibition of GSC proliferation in vitro (MTT, Trypan blue exclusion assays, and EdU labeling) and in vivo (zebrafish model), migration (Boyden chamber assay), invasiveness (Matrigel invasion assay), self-renewal (spher"],"journal":["Journal of experimental & clinical cancer research : CR"],"pagination":["53"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8822754"],"repository":["biostudies-literature"],"pubmed_title":["Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives."],"pmcid":["PMC8822754"],"pubmed_authors":["Cianci F","Schenone S","Bosio AG","Tonelli M","Daga A","Francesconi V","Bajetto A","Zona G","Fiaschi P","Malatesta P","Mazzetti S","Mazzanti M","Balboni B","Palloni LMG","Florio T","Cannavale G","Pattarozzi A","Girotto S","Verduci I","Thellung S","Barbieri F"],"additional_accession":[]},"is_claimable":false,"name":"Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives.","description":"<h4>Background</h4>Chloride intracellular channel-1 (CLIC1) activity controls glioblastoma proliferation. Metformin exerts antitumor effects in glioblastoma stem cells (GSCs) inhibiting CLIC1 activity, but its low potency hampers its translation in clinical settings.<h4>Methods</h4>We synthesized a small library of novel biguanide-based compounds that were tested as antiproliferative agents for GSCs derived from human glioblastomas, in vitro using 2D and 3D cultures and in vivo in the zebrafish model. Compounds were compared to metformin for both potency and efficacy in the inhibition of GSC proliferation in vitro (MTT, Trypan blue exclusion assays, and EdU labeling) and in vivo (zebrafish model), migration (Boyden chamber assay), invasiveness (Matrigel invasion assay), self-renewal (spher","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Feb","modification":"2025-04-04T08:41:08.91Z","creation":"2024-11-13T10:33:52.156Z"},"accession":"S-EPMC8822754","cross_references":{"pubmed":["35135603"],"doi":["10.1186/s13046-021-02213-0"]}}